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Raskausajan diabetes kehittyy 3-5 % raskaana olevista naisista. Se altistaa erityisesti tyypin 2 
diabetekselle ja metaboliselle oireyhtymälle sekä sydän- ja verisuonisairauksille myöhemmin 
elämässä. Lisäksi hapettuneet LDL-lipidit ovat riskitekijä sydän- ja verisuonisairauksille ja niiden 
pitoisuus verenkierrossa on suurentunut diabeteksessa. 
 
Vertasimme seerumin rasva-aineiden ja hapettuneiden LDL-lipidien tasoja raskausajan 
diabeetikoilla raskaana oleviin naisiin, joiden sokeriaineenvaihdunta on normaali. Raskausajan 
diabetes määritettiin oraalisella glukoosirasituskokeella raskausviikoilla 8-12. Verinäytteistä 
tutkimme seerumin kokonaiskolesterolin, triglyseridit, HDL- ja LDL-kolesterolit, hapettuneet LDL-
lipidit sekä paraoksonaasi- ja insuliinitasot.  
 
619 osallistujasta 28 % oli raskausajan diabetes. Raskausajan diabeetikoilla oli suurempi 
hapettuneiden LDL-lipidien suhde HDL-kolesteroliin (p=0,012) ja suurempi seerumin 
triglyseridipitoisuus (p=0,049) sekä pienempi HDL-kolesterolipitoisuus (p=0,016). Lisäksi jaoimme 
osallistujat kolmeen ryhmään insuliinipitoisuuden mukaan. Henkilöillä, joiden insuliinipitoisuus oli 
korkein, oli suurempi triglyseridipitoisuus (p=0,005) ja suurempi hapettuneiden LDL-lipidien suhde 
HDL-kolesteroliin (p=0,049). Tuloksissa huomioitiin tupakointi, painoindeksi ja ikä.
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 Abstract 
 
We investigated the effect of altered glucose metabolism and high insulin concentration on oxidized 
LDL lipids and serum lipids during early pregnancy. During early pregnancy (gestational weeks 8-
12), 691 women took part in measurements for oral glucose tolerance test (OGTT), serum lipids and 
oxidized LDL lipids (ox-LDL). Based on the OGTT, subjects were divided to pathological OGTT 
and normal OGTT. Further, subjects were stratified into tertiles according to their insulin levels 
(low, average and high insulin level). Ox-LDL was determined by baseline level of conjugated 
dienes in LDL lipids. Women with pathological OGTT had significantly higher serum triglycerides 
and ratio of ox-LDL to HDL-cholesterol and lower HDL-cholesterol than women with normal 
OGTT after controlling BMI, age and smoking status (p=0.049, p=0.012 and p=0.016, 
respectively). In insulin tertiles, the women with low insulin level had significantly lower serum 
triglycerides and the ratio of ox-LDL to HDL-cholesterol than the women with high insulin level 
(p=0.005 and  p=0.049, respectively) after adjusting for BMI, age and smoking. To conclude, 
pathological OGTT and high concentration of serum insulin were associated with elevated level of 
serum triglyceride and high ratio of oxidized LDL lipids to HDL-cholesterol after adjusting the 
results for BMI, age and smoking during early pregnancy. The present study showed that 
pathological glucose metabolism during early pregnancy may be associated with atherogenic lipid 
profile. 
 Introduction 
 
It is estimated that around 3-5 % of pregnant women develop gestational diabetes mellitus (GDM) 
(1,2). In Finland the prevalence of GDM varies between 7 to 25 % (3). During pregnancy insulin 
sensitivity decreases which may lead to glucose intolerance and GDM (4). In a majority of women 
with GDM glucose metabolism normalizes after delivery but they still have an increased risk of 
diabetes mellitus or impaired glucose tolerance (IGT) and metabolic syndrome later in their life. 
GDM also increases the risk of obesity among women and their children (5-8). 
 
Major risk factors of GDM are increasing maternal age, family history of type 2 diabetes, 
overweight before pregnancy, high pregnancy weight gain, lack of physical activity before 
pregnancy (9,10) and GDM or IGT during earlier pregnancies (6).  There are some evidence that 
high intake of saturated fat and low intake of polyunsaturated fat increase the risk of developing 
GDM (2,11-13). In earlier studies, prevention of gestational weight gain by dietary and physical 
activity counseling have found to be favorable and structured aerobic exercise training has been 
shown to decrease birth weight of the newborns (14,15).  
 
LDL molecules may be oxidatively modified under certain conditions (16). Oxidized LDL lipids 
(Ox-LDL) are a known risk factor of atherosclerotic diseases, like coronary artery disease (17,18). 
Diabetes mellitus is associated with increased oxidative stress, increased ratio of the oxidized LDL 
to LDL cholesterol (reviewed in (19)) and increased levels of oxidized LDL (20). Although Kathir 
et al. found no increase in amount of oxidized fatty acids or cholesterol in diabetic subjects (21).  
 
In this study, we investigated the effect of altered glucose metabolism and high insulin 
concentration on oxidized LDL lipids and serum lipids during early pregnancy. We hypothesized 
that gestational diabetes and elevated concentration of insulin are associated with high 
concentration of oxidized LDL and unfavorable serum lipids in a large sample of pregnant women.  
 
 
 Materials and Methods 
 
The cohort study was collected from primary health care maternity clinics in Pirkanmaa region, 
situated south-western part of Finland. The nurses recruited 2071 pregnant women when they 
contacted the maternity clinic for the first time by telephone (up to 12 weeks’ gestation) (22). 
Pregnant women were eligible for the study if they had at least one of the following risk factors: 
body mass index (BMI) ≥ 25 kg/m², GDM or any signs of glucose intolerance or macrosomic 
newborn (≥ 4500g) in any earlier pregnancy, type 1 or 2 diabetes in first or second grade relatives 
or age ≥ 40 years. Exclusion criteria were pre-pregnant type 1 or 2 diabetes, inability to speak 
Finnish, age < 18 years, twin pregnancy, physical restriction preventing from physical activity, 
substance abuse, treatment or clinical history of psychiatric illness. 1016 women were eligible and 
from 619 women, the fasting blood sample was taken and oral glucose tolerance test was 
conducted. Ethical approval for this study was obtained from the Ethical board of Pirkanmaa 
Hospital District. 
  
 
Oral glucose tolerance test 
Oral glucose tolerance test (OGTT) was taken at 8-12 weeks’ gestation. Analyses were performed 
at the UKK Institute. The standard OGTT was performed by giving GlukodynR, including 75 g 
glucose in 330 ml water after overnight fasting (8 to 14 hours). The Finnish GDM criteria were used 
to identify participants with GDM: abnormal fasting blood glucose ≥5.3 mmol/l, >10.0 mmol/l at 1-
hour and >8.6 mmol/l at 2-hour (23). 
 
 
Laboratory tests 
Analyses of blood samples included determination of serum lipids (cholesterol, HDL-cholesterol, 
triglycerides, LDL-cholesterol), oxidized LDL lipids and other biological markers as paraoxonase 
and insulin. Medical laboratory technologists from the UKK Institute or from the Centre Laboratory 
of Medicine in Pirkanmaa hospital district took the blood samples (4 × 10 ml) and performed the 
OGTT for all participating pregnant women. For lipid analyses venous blood was drawn into EDTA 
tubes. Plasma samples were stored frozen at -80C until analyzed. Samples were analyzed in MCA 
research laboratory, Turku (paraoxonase, insulin and oxidized LDL lipids) and at the UKK Institute 
(serum lipids and glucose). For assessment of LDL-cholesterol and baseline diene conjugation (ox-
LDL) (24), LDLc was first isolated by precipitation (24,25). The coefficient of variation (CV) for 
the within-assay precision (12 determinations of the same serum) of the precipitation phase was 
3.6%. After resuspension of the LDLc, the concentration of cholesterol was measured using a kit 
(CHOD-PAP method, Boehringer Mannheim, Mannheim, Germany). Thereafter, lipids were 
extracted from the LDLc samples (100 l) by chloroform – methanol (2:1), dried under nitrogen, 
then redissolved in cyclohexane, and analyzed spectrophotometrically at 234 nm (26). Oxidation 
during the sample preparation was prevented by EDTA. The CV for the within-assay precision was 
4.4 % (20 determinations of the same sample); the CV for the between-assay precision was 4.5 % 
(over the period of 3 months). Total cholesterol, HDL cholesterol and triglyceride concentrations 
were measured with enzymatic assays using Roche Cobas Mira Plus analyzer. Paraoxonase activity 
was determined using paraoxon (O,O-diethyl-O-p-nitrophenylphosphate) as the substrate (27).  
Serum insulin was measured with time-resolved fluoroimmunoassay method using Wallac 
AutoDELFIA analyzer (Wallac, Turku, Finland). All analyses were made in duplicate. 
 
Statistical analysis 
First we divided women into two groups based on their oral glucose tolerance test results: women 
with pathological OGTT and women with normal OGTT. Further, we divided women into tertiles 
based on their serum insulin levels: the low insulin group (serum insulin level less than 9.40 mU/L), 
the average insulin group (serum insulin level 9.40 – 13.30 mU/L) and the high insulin group 
(serum insulin level greater than 13.30 mU/L). 
 
Univariable and multivariable linear regression analyses were used to test the differences between 
groups. We adjusted our multivariable models for body mass index, age and smoking. Based on 
Kolmogorov-Smirnov test the residuals of triglyceride, paraoxonase, ox-LDL and ratios of ox-LDL 
to HDL-cholesterol and ox-LDL to LDL-cholesterol were not normally distributed and therefore 
these dependent variables were examined after logarithmic transformation. Spearman’s rank 
correlation coefficient was used to determine the association between lipids and the concentration 
of insulin and between lipids and the concentration of 2 h glucose from OGTT. 
 
A P value of less than 0.05 was considered to indicate statistical significance. All statistical analyses 
were two-tailed and performed using STATA version 12.0 for Windows (StataCorp LP, College 
Station, Texas, USA). 
 
 Results 
 
From the 619 women tested, 173 women (28 %) had pathological OGTT. 
 
Pathological OGTT vs. normal OGTT  
Women with pathological OGTT had significantly higher serum triglycerides than women with 
normal OGTT (1.33 vs. 1.17, p<0.001; regression coefficient 0.14 and 95% confidence interval 
(95% CI) 0.06-0.23). Also, they had significantly higher, concentration of ox-LDL (26.8 vs. 25.6, 
p=0.026; coefficient 1.15 and 95% CI 0.13-2.25). Women with pathological OGTT had 
significantly lower HDL-cholesterol than women with normal OGTT (1.58 vs. 1.69, p<0.001, 
coefficient -0.11 and 95% CI -0.17 to -0.06). After adjusting the results for BMI, age and smoking 
the ratio of ox-LDL to HDL-cholesterol, concentration of HDL-cholesterol and serum triglycerides 
remain significant between women with pathological and normal OGTT (p=0.012, p=0.016 and 
p=0.049, respectively). There were no significant difference between women with pathological and 
normal OGTT in concentrations of serum total cholesterol, LDL-cholesterol, paraoxonase and the 
ratio of ox-LDL to LDL-cholesterol (Table 1). 
 
Insulin tertiles 
We divided women into three groups based on their serum insulin levels: insulin < 9.40 mU/L (low 
insulin group), 9.40 – 13.30 mU/L (average insulin group) and >13.30 mU/L (high insulin group) 
(Table 2). Concentration of serum triglycerides was lower in the low insulin group compared to the 
high insulin group (coefficient 0.23 and 95% CI 0.14-0.32). The women with low insulin level had 
significantly higher HDL-cholesterol than the women with high insulin level (coefficient -0.13 and 
95% CI -0.19 to -0.07). Concentration of ox-LDL was significantly lower in the low insulin group 
compared to the high insulin group (coefficient 0.05 and 95% CI 0.01-0.10). The ratio of ox-LDL to 
HDL-cholesterol was significantly lower in the low insulin group compared to the high insulin 
group (coefficient 0.14 and 95% CI 0.08-0.19). There were no significant difference between 
groups in concentrations of serum total cholesterol, LDL-cholesterol, paraoxonase and the ratio of 
ox-LDL to LDL-cholesterol. After adjusting the results for BMI, age and smoking the difference 
remained significant between the low insulin and high insulin groups in serum triglycerides and the 
ratio of ox-LDL to HDL-cholesterol (coefficient 0.14 and 95% CI 0.04-0.25 and coefficient 0.07 
and 95% CI 0.00-0.13, respectively), while no other differences were seen in other variables 
between the insulin groups. 
 Correlations 
The concentration of insulin correlated slightly positively with triglyceride (r=0.21, p<0.0001), ox-
LDL (r=0.094, p=0.020), and with the ratios of ox-LDL to HDL-cholesterol (r=0.20, p<0.0001) and 
ox-LDL to LDL-cholesterol (r=0.080, p=0.047), and negatively with HDL-cholesterol (r=-0.20, 
p<0.0001), while no significant correlations were found with cholesterol, LDL-cholesterol and 
paraoxonase.  
 
The concentration of 2 h glucose from OGTT correlated positively with triglyceride (r=0.31, 
p<0.0001), ox-LDL (r=0.23, p<0.0001), cholesterol (r=0.14, p=0.004), LDL-cholesterol (r=0.16, 
p=0.001) and with the ratio of ox-LDL to HDL-cholesterol (r=0.29, p<0.0001), and negatively with 
HDL-cholesterol (r=-0.17, p<0.0001), while no significant correlations were found with and 
paraoxonase and the ratio ox-LDL to LDL-cholesterol.  
 
 
Discussion 
 
We reported that pathological OGTT and high concentration of serum insulin (>13.3 mU/L) are 
both associated with elevated level of serum triglyceride and high ratio of oxidized LDL lipids to 
HDL-cholesterol after adjusting the results for BMI, age and smoking during early pregnancy. To 
our knowledge, this is the first study to demonstrate that pathological glucose metabolism during 
early pregnancy is associated with elevated ratio of ox-LDL to HDL-cholesterol. This finding may 
have clinical significance, because the ratio of ox-LDL to HDL-cholesterol is known to predict 
coronary artery disease and all-cause mortality (28,29). 
 
Ox-LDL is known risk factor of atherosclerosis and other CVD. On the other hand, HDL-
cholesterol and especially the beneficial functions of HDL are known to have cardioprotective 
effects. This protection includes anti-inflammation, LDL-specific antioxidant activity and 
upregulation of nitric oxide (30). Further, we recently reported that HDL has an active role in body 
clearance of lipid peroxides during physiological oxidative stress like post-prandial state and during 
physical exercise (27). Therefore, the ratio of ox-LDL to HDL-cholesterol may be a suitable marker 
when measuring cardiometabolic risk associated with conditions like GDM. In the present study, 
both women with pathological OGTT compared to women with normal OGTT and the women with 
high insulin level compared to women with low insulin level had significantly higher the ratio of 
ox-LDL to HDL-cholesterol. These differences were significant after adjusting BMI, age and 
smoking. Also, the concentration of HDL-cholesterol differed according to the OGTT. The women 
with normal OGTT had 7% higher concentration of HDL-cholesterol than women with pathological 
OGTT. Similarly, the women with low insulin level had 8% higher concentration of HDL-
cholesterol than women with high insulin level, although this difference was no more significant 
after adjusting BMI, age and smoking. These results underline, that altered glucose metabolism 
already during early pregnancy is associated with atherogenic changes in serum HDL-cholesterol 
and the ratio of ox-LDL to HDL-cholesterol. 
 
Serum concentration of triglyceride is known to increase during pregnancy (31). In the present 
study, women with pathological OGTT had 14% higher concentration of triglycerides compared to 
women with normal OGTT. Similarly, the women with high insulin level had 21% higher 
concentration of serum triglycerides compared to women with low insulin level. These differences 
persisted after controlling BMI, age and smoking. The concentration of ox-LDL was higher in 
women with pathological OGTT compared to the women normal OGTT and similarly in the women 
with high insulin level compared to women with low insulin level. However, these differences 
disappeared when BMI, age and smoking were controlled, which suggests that BMI as an important 
risk factor of abnormalities in glucose metabolism is also strongly associated with concentrations of 
ox-LDL as also shown in healthy girls and obese men (32,33). Interestingly, the concentration of 
LDL-cholesterol did not differ neither between women with normal and pathological OGTT nor 
between women with high and low insulin level. Therefore, in contrast to oxidized LDL lipids, the 
native LDL-cholesterol seems not be associated with altered glucose metabolism during early 
pregnancy. These results indicated that altered glucose metabolism (pathological OGTT or high 
insulin concentration) was associated with elevated level of serum triglycerides and oxidized LDL 
lipids already during early pregnancy, while serum cholesterol and LDL-cholesterol did not 
associate with altered glucose metabolism.  
 
Paraoxonase is a HDL –associated enzyme, which is implicated in the lipid metabolism and 
suggested to play a role in the antioxidant function of HDL. Some earlier studies have measured 
elevated activities of paraoxonase during pregnancy (34,35). In the present study, the activity of 
paraoxonase did not differ between the women with pathological and normal OGTT. In the present 
study, the concentration of paraoxonase did not differ between the women with pathological and 
normal OGTT. Neither was there any difference in paraoxonase between the tertiles of insulin. 
Therefore, paraoxonase related antioxidant activity of HDL is not the obvious mediator of lower 
ratio of ox-LDL to HDL-cholesterol observed in the present study. 
 
The concentration of insulin correlated strongest with triglyceride (r=0.21), HDL-cholesterol (r=-
0.20) and the ratio of ox-LDL to HDL-cholesterol (r=0.20). This is in line with earlier study, where 
insulin concentration was associated with ox-LDL (r=0.25, p<0.0001) in 766 Finnish women aged 
24 to 39 years (36). We also investigated how the concentration of 2 h glucose from OGTT 
correlated with ox-LDL and serum lipids. The strongest correlations were shown against 
triglycerides (r=0.31), the ratio of ox-LDL to HDL-cholesterol (r=0.29) and interestingly with ox-
LDL (r=0.23). These results suggested that concentrations of triglyceride, HDL-cholesterol, ox-
LDL and also the ratio of ox-LDL to HDL-cholesterol were the lipid variables that strongest related 
with the measures of glucose metabolism, insulin and 2 h glucose from OGTT. Therefore, the above 
mentioned lipid variables might be the key measures when estimating lipid risk factors during early 
pregnancy. 
 
The current study is based on the quite large sample of women who all underwent also OGTT 
during early pregnancy. This gives statistical power to the analysis. We were able to handle the 
known factors (like BMI, age and smoking) that could interfere with the lipid results. Therefore, we 
consider that the results are reliable.  
 
In conclusion, pathological OGTT and high concentration of serum insulin were associated with 
elevated level of serum triglyceride and high ratio of oxidized LDL lipids to HDL-cholesterol after 
adjusting the results for BMI, age and smoking during early pregnancy. Also, strongest correlations 
between measures of glucose metabolism (concentration of insulin and 2 h glucose from OGTT) 
and lipids were shown in serum triglyceride, HDL-cholesterol, oxidized LDL and the ratio of 
oxidized LDL lipids to HDL-cholesterol. The present study showed that pathological glucose 
metabolism during early pregnancy may be associated with atherogenic lipid profile. 
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 Table 1. Serum oxidized LDL lipids and serum lipids in women with pathological OGTT and in 
women with normal OGTT. Means and standard deviation (SD). Regression coefficients (95% 
confidence intervals) from four regression models. 
 
 OGTT 
pathological 
OGTT 
normal 
Model 1 Model 2 Model 3 Model 4 
Cholesterol 4.70 (0.79) 4.65 (0.74) 0.05  
(-0.08 to 0.18) 
0.05  
(-0.11 to 0.22) 
0.06  
(-0.11 to 0.22) 
0.06  
(-0.11 to 0.22) 
HDL 1.58 (0.30) 1.69 (0.30) -0.11  
(-0.17 to -0.06) 
-0.07 
 (-0.14 to -0.01) 
-0.07  
(-0.14 to -0.01) 
-0.08  
(-0.15 to -0.02) 
LDL 2.52 (0.65) 2.43 (0.58) 0.09 
 (-0.02 to 0.19) 
0.07  
(-0.06 to 0.20) 
0.08  
(-0.05 to 0.21) 
0.08 
 (-0.05 to 0.21) 
Triglycerides  1.33 (0.54) 1.17 (0.42) 0.14  
(0.06 to 0.23) 
0.05 
 (0.00 to 0.12) 
0.05  
(0.00 to 0.12) 
0.05 
(0.00 to 0.013) 
Paraoxonase  36.4 (21.3) 37.9 (23.2) -0.81  
(-3.70 to 2.80) 
-0.90  
(-3.22 to 3.92) 
-0.57  
(-2.46 to 4.76) 
-0.39 
 (-2.33 to 5.16) 
Ox-LDL  26.8 (6.1) 25.6 (5.8) 1.15  
(0.13 to 2.25) 
0.66  
(-0.31 to 1.90) 
0.59  
(-0.32 to 1.89) 
0.55  
(-0.38 to 1.91) 
Ox-LDL / LDL  12.4 (2.9) 12.4 (2.7) -0.02  
(-0.46 to 0.46) 
-0.17  
(-0.67 to 0.48) 
-0.22 
 (-0.70 to 0.47) 
-0.26  
(-0.75 to 0.45) 
Ox-LDL / HDL  17.7 (5.6) 15.7 (4.7) 1.87 
 (0.99 to 2.85) 
0.76 
 (0.15 to 1.59) 
0.75  
(0.13 to 1.70) 
0.80 
 (0.14 to 1.81) 
 
OGTT oral glucose tolerance test 
Model 1: Unadjusted linear regression model 
Model 2: Adjusted for body mass index 
Model 3: Adjusted for body mass index and age 
Model 4: Adjusted for body mass index, age and smoking 
 
 
 
 Table 2. Serum oxidized LDL lipids and serum lipids in insulin tertiles (low (<9.4 mU/L), average 
(9.4-13.3 mU/L) and high (>13.3 mU/L) insulin group). Means and standard deviation (SD). 
Regression coefficients (95% confidence intervals) from four regression models using low insulin 
group as a reference group. 
 
 Insulin Mean 
(SD) 
Model 1 Model 2 Model 3 
 
Cholesterol Low  4.67 (0.79)    
 Average  4.71 (0.76) 0.04  
(-0.10 to 0.19) 
0.06  
(-0.10 to 0.21) 
0.07  
(-0.09 to 0.22) 
 High  4.63 (0.71) -0.03  
(-0.18 to 0.11) 
-0.10  
(-0.28 to 0.07) 
-0.08  
(-0.26 to 0.09) 
HDL Low  1.72 (0.31)    
 Average  1.66 (0.29) -0.06  
(-0.12 to 0.00) 
-0.03  
(-0.09 to 0.03) 
-0.03  
(-0.09 to 0.03) 
 High  1.59 (0.30) -0.13  
(-0.19 to -0.07) 
-0.06  
(-0.13 to 0.01) 
-0.06  
(-0.13 to 0.01) 
LDL Low  2.44 (0.59)    
 Average  2.51 (0.62) 0.07 
 (-0.05 to 0.18) 
0.07  
(-0.05 to 0.19) 
0.08  
(-0.04 to 0.20) 
 High  2.43 (0.58) -0.01  
(-0.13 to 0.11) 
-0.11  
(-0.24 to 0.03) 
-0.10  
(-0.23 to 0.04) 
Triglycerides  Low  1.11 (0.40)    
 Average  1.19 (0.39) 0.07  
(-0.02 to 0.16) 
0.03  
(-0.06 to 0.12) 
0.04  
(-0.05 to 0.13) 
 High  1.34 (0.56) 0.23 
 (0.14 to 0.32) 
0.13  
(0.03 to 0.23) 
0.14  
(0.04 to 0.25) 
Paraoxonase  Low  39.1 (23.8)    
 Average  36.3 (21.9) -0.08 
 (-0.19 to 0.04) 
-0.04  
(-0.17 to 0.08) 
-0.05  
(-0.18 to 0.07) 
 High  37.2 (22.2) -0.04  
(-0.16 to 0.07) 
-0.04  
(-0.17 to 0.10) 
-0.03  
(-0.17 to 0.11) 
Ox-LDL  Low  25.3 (6.1)    
 Average  25.8 (5.6) 0.02  
(-0.02 to 0.07) 
0.02  
(-0.03 to 0.06) 
0.02 
 (-0.03 to 0.06) 
 High  26.6 (6.0) 0.05  
(0.01 to 0.10) 
0.03  
(-0.02 to 0.08) 
0.03  
(-0.02 to 0.08) 
Ox-LDL / LDL  Low  12.3 (2.8)    
 Average  12.2 (2.8) -0.00  
(-0.05 to 0.04) 
-0.01  
(-0.06 to 0.03) 
-0.01  
(-0.06 to 0.03) 
 High  12.7 (2.6) 0.04  
(-0.00 to 0.08) 
0.05 
 (0.00 to 0.10) 
0.05  
(-0.00 to 0.10) 
Ox-LDL / HDL  Low  15.2 (4.5)    
 Average  16.1 (4.8) 0.06  
(-0.00 to 0.11) 
0.03  
(-0.03 to 0.09) 
0.03  
(-0.03 to 0.09) 
 High  17.5(5.5) 0.14  
(0.08 to 0.19) 
0.06  
(0.00 to 0.13) 
0.07  
(0.00 to 0.13) 
 
Model 1: Unadjusted linear regression model 
Model 2: Adjusted for body mass index 
Model 3: Adjusted for body mass index, age and smoking 
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